tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Imugene Achieves 81% Response Rate in CAR T-cell Therapy Trial
Company AnnouncementsImugene Achieves 81% Response Rate in CAR T-cell Therapy Trial
18h ago
Imugene Reports Promising Results in CAR T-Naïve Lymphoma Trial
PremiumCompany Announcements
Imugene Reports Promising Results in CAR T-Naïve Lymphoma Trial
3d ago
Imugene’s PD1-Vaxx Colorectal Cancer Trial to Feature at ESMO 2025
PremiumCompany Announcements
Imugene’s PD1-Vaxx Colorectal Cancer Trial to Feature at ESMO 2025
12d ago
Imugene Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Imugene Expands Market Presence with New Securities Quotation
19d ago
Imugene Announces 2025 Annual General Meeting and Remuneration Enhancements
PremiumCompany Announcements
Imugene Announces 2025 Annual General Meeting and Remuneration Enhancements
19d ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
PremiumCompany AnnouncementsImugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
1M ago
Imugene Issues Over 5.5 Million Quoted Options to SPP Participants
Premium
Company Announcements
Imugene Issues Over 5.5 Million Quoted Options to SPP Participants
2M ago
Imugene Expands Market Presence with New Securities Quotation
Premium
Company Announcements
Imugene Expands Market Presence with New Securities Quotation
2M ago
Imugene Completes Share Purchase Plan, Raising $2.42 Million
PremiumCompany Announcements
Imugene Completes Share Purchase Plan, Raising $2.42 Million
2M ago
Imugene Limited Reveals Top Security Holders
PremiumCompany Announcements
Imugene Limited Reveals Top Security Holders
2M ago
Imugene Limited Announces New Quotation of Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces New Quotation of Securities on ASX
2M ago
Imugene Limited Reports Progress in Cancer Therapy Development
PremiumCompany Announcements
Imugene Limited Reports Progress in Cancer Therapy Development
2M ago
Imugene Releases 2025 Corporate Governance Statement
PremiumCompany AnnouncementsImugene Releases 2025 Corporate Governance Statement
2M ago
Imugene Announces Successful Outcomes of Extraordinary General Meeting
Premium
Company Announcements
Imugene Announces Successful Outcomes of Extraordinary General Meeting
2M ago
Imugene Extends Share Purchase Plan Deadline
Premium
Company Announcements
Imugene Extends Share Purchase Plan Deadline
3M ago
Imugene Extends Share Purchase Plan Deadline to Enhance Shareholder Participation
PremiumCompany Announcements
Imugene Extends Share Purchase Plan Deadline to Enhance Shareholder Participation
3M ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
PremiumCompany Announcements
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
3M ago
Imugene Issues Over 68 Million Shares to Fund Immunotherapy Advancements
PremiumCompany Announcements
Imugene Issues Over 68 Million Shares to Fund Immunotherapy Advancements
3M ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces Quotation of New Securities on ASX
3M ago
Imugene Limited Announces Director’s Interest Change
PremiumCompany AnnouncementsImugene Limited Announces Director’s Interest Change
3M ago
Imugene Limited Expands Market Presence with New Securities Quotation
Premium
Company Announcements
Imugene Limited Expands Market Presence with New Securities Quotation
3M ago
Imugene Announces Extraordinary General Meeting for 2025
Premium
Company Announcements
Imugene Announces Extraordinary General Meeting for 2025
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >